drugset / Trial / NCT00727948

The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy

NCT00727948

Phase 0 Completed 11 enrolled University of Vermont
NaSingle-groupOpen-labelTreatment

Summary

Changes in major angiogenic proteins have been seen following initiation of tamoxifen and aromatase inhibitor therapy in women with breast cancer. One source of these proteins is the circulating platelet pool. The investigators hypothesize that in addition to their anti-platelet properties, agents such as aspirin can be used as targeted anti-angiogenesis therapy. The investigators will determine the influence of aspirin on the release of angiogenic proteins from platelets in 35 patients with breast cancer.

Timeline

Start
2008-07
Primary completion
2010-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 325 mg

Indications